Announced
Completed
Synopsis
The Carlyle Group completed the $700m investment in MAK-SYSTEM, a provider of software solutions supporting the entire blood chain management process. "We are delighted at the opportunity to be working with Carlyle, one of the most predominant investors in the healthcare space. This partnership will enable us to better serve our clients and rapidly extend our footprint with numerous innovations," Simon Kiskovski, MAK Founder.
Principals
Show Details & Financials
Sort
Search a database of more than 250,000 verified dealmakers
Receive automated updates on global transactions
Follow the activity, relationships and transactions of top dealmakers
© COPYRIGHT 2024 MERGERLINKS LIMITED.
ALL RIGHTS RESERVED.
15 BONHILL STREET, LONDON, EC2A 4DN, UNITED KINGDOM.